ReP USP - Resultado da busca

Artigo de periodico
Reversine triggers mitotic catastrophe and apoptosis in K562 cells (2016)
Alves, Ana Paula Nunes Rodrigues; Machado Neto, João Agostinho ; Scheucher, Priscila Santos; Paiva, Helder Henrique; Simões, Belinda Pinto; Rego, Eduardo Magalhães; Traina, Fabiola
Source: Leukemia Research. Unidade: FMRP
Subjects: APOPTOSE, PROTEÍNAS QUINASES, LEUCEMIA MIELOIDE, DOENÇA CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Ana Paula Nunes Rodrigues et al. Reversine triggers mitotic catastrophe and apoptosis in K562 cells. Leukemia Research, v. 48, p. 26-31, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2016.06.011. Acesso em: 18 nov. 2024.
APA
Alves, A. P. N. R., Machado Neto, J. A., Scheucher, P. S., Paiva, H. H., Simões, B. P., Rego, E. M., & Traina, F. (2016). Reversine triggers mitotic catastrophe and apoptosis in K562 cells. Leukemia Research, 48, 26-31. doi:10.1016/j.leukres.2016.06.011
NLM
Alves APNR, Machado Neto JA, Scheucher PS, Paiva HH, Simões BP, Rego EM, Traina F. Reversine triggers mitotic catastrophe and apoptosis in K562 cells [Internet]. Leukemia Research. 2016 ; 48 26-31.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2016.06.011
Vancouver
Alves APNR, Machado Neto JA, Scheucher PS, Paiva HH, Simões BP, Rego EM, Traina F. Reversine triggers mitotic catastrophe and apoptosis in K562 cells [Internet]. Leukemia Research. 2016 ; 48 26-31.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2016.06.011
Artigo de periodico
Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 (2014)
Campos, Paula de Melo; Machado Neto, João Agostinho ; Scopim-Ribeiro, Renata; Visconte, Valeria; Tabarroki, Ali; Duarte, Adriana S. S; Barra, Flávia F. C; Vassalo, José; Rogers, Heesun J; Lorand-Metze, Irene; Tiu, Ramon V; Costa, Fernando F; Saad, Sara T. Olalla; Traina, Fabiola
Source: Leukemia Research. Unidade: FMRP
Subjects: APOPTOSE (EFEITOS DE DROGAS), PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, v. 38, n. 10, p. 1245-1251, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2014.07.010. Acesso em: 18 nov. 2024.
APA
Campos, P. de M., Machado Neto, J. A., Scopim-Ribeiro, R., Visconte, V., Tabarroki, A., Duarte, A. S. S., et al. (2014). Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412. Leukemia Research, 38( 10), 1245-1251. doi:10.1016/j.leukres.2014.07.010
NLM
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Vancouver
Campos P de M, Machado Neto JA, Scopim-Ribeiro R, Visconte V, Tabarroki A, Duarte ASS, Barra FFC, Vassalo J, Rogers HJ, Lorand-Metze I, Tiu RV, Costa FF, Saad STO, Traina F. Familial systemic mastocytosis with germline KIT K509I mutation is sensitive to treatment with imatinib, dasatinib and PKC412 [Internet]. Leukemia Research. 2014 ; 38( 10): 1245-1251.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2014.07.010
Artigo de periodico
The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes (2010)
Costa, Simone V. da; Roela, Rosimeire A.; Junqueira, Mara Souza; Arantes, Camila; Brentani, Maria Mitzi
Source: Leukemia Research. Unidade: FM
Subjects: PROTEÍNAS QUINASES, LEUCEMIA, NEOPLASIAS DA MEDULA ESPINHAL, CÉLULAS-TRONCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Simone V. da et al. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, v. 34, n. 4, p. 507-512, 2010Tradução . . Disponível em: https://doi.org/10.1016/j.leukres.2009.10.012. Acesso em: 18 nov. 2024.
APA
Costa, S. V. da, Roela, R. A., Junqueira, M. S., Arantes, C., & Brentani, M. M. (2010). The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes. Leukemia Research, 34( 4), 507-512. doi:10.1016/j.leukres.2009.10.012
NLM
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012
Vancouver
Costa SV da, Roela RA, Junqueira MS, Arantes C, Brentani MM. The role of p38 mitogen-activated protein kinase in serum-induced leukemia inhibitory factor secretion by bone marrow stromal cells from pediatric myelodysplastic syndromes [Internet]. Leukemia Research. 2010 ; 34( 4): 507-512.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.leukres.2009.10.012

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Indexado em